Terms: = Prostate cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Diagnosis
15 results:
1. Strong pd-l1 expression in granulomatous prostatitis.
Dikov D; Koleva M; Mollova A; Fakirova A
Prostate; 2023 Sep; 83(13):1285-1289. PubMed ID: 37357498
[TBL] [Abstract] [Full Text] [Related]
2. Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade.
Röbeck P; Franzén B; Cantera-Ahlman R; Dragomir A; Auer G; Jorulf H; Jacobsson SP; Viktorsson K; Lewensohn R; Häggman M; Ladjevardi S
Cytopathology; 2023 Jul; 34(4):286-294. PubMed ID: 36840380
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.
Huang G; Zhang H; Shi H; Zhang W; Wang T; Wang Z; Chen Q; Lian B; Li J; Yang G
World J Surg Oncol; 2022 Dec; 20(1):407. PubMed ID: 36572885
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein b7-h3, and with poor prognosis in prostate cancer.
Nunes-Xavier CE; Emaldi M; Guldvik IJ; Ramberg H; Taskén KA; Mælandsmo GM; Fodstad Ø; Llarena R; Pulido R; López JI
Pathol Res Pract; 2023 Jan; 241():154243. PubMed ID: 36481650
[TBL] [Abstract] [Full Text] [Related]
5. Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates.
Cantley RL; Wang X; Reichert ZR; Chinnaiyan AM; Mannan R; Cao X; Spratt DE; Vaishampayan UN; Alumkal JJ; Morgan TM; Palapattu G; Davenport MS; Pantanowitz L; Mehra R
Cancer Cytopathol; 2023 Feb; 131(2):117-135. PubMed ID: 36264673
[TBL] [Abstract] [Full Text] [Related]
6. The state of the art for artificial intelligence in lung digital pathology.
Viswanathan VS; Toro P; Corredor G; Mukhopadhyay S; Madabhushi A
J Pathol; 2022 Jul; 257(4):413-429. PubMed ID: 35579955
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatics Analysis of GFAP as a Potential Key Regulator in Different Immune Phenotypes of prostate cancer.
Yao W; Li X; Jia Z; Gu C; Jin Z; Wang J; Yuan B; Yang J
Biomed Res Int; 2021; 2021():1466255. PubMed ID: 34222466
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.
Signore M; Alfonsi R; Federici G; Nanni S; Addario A; Bertuccini L; Aiello A; Di Pace AL; Sperduti I; Muto G; Giacobbe A; Collura D; Brunetto L; Simone G; Costantini M; Crinò L; Rossi S; Tabolacci C; Diociaiuti M; Merlino T; Gallucci M; Sentinelli S; Papalia R; De Maria R; Bonci D
Cell Death Dis; 2021 Jun; 12(7):636. PubMed ID: 34155195
[TBL] [Abstract] [Full Text] [Related]
9. Nucleic acids therapeutics using PolyPurine Reverse Hoogsteen hairpins.
Noé V; Aubets E; Félix AJ; Ciudad CJ
Biochem Pharmacol; 2021 Jul; 189():114371. PubMed ID: 33338475
[TBL] [Abstract] [Full Text] [Related]
10. Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients.
Ihle CL; Provera MD; Straign DM; Smith EE; Edgerton SM; Van Bokhoven A; Lucia MS; Owens P
J Immunother Cancer; 2019 Nov; 7(1):293. PubMed ID: 31703602
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study.
Jung M; Kim S; Lee JK; Yoon SO; Park HS; Hong SW; Park WS; Kim JE; Kim J; Keam B; Kim HJ; Kang HJ; Kim DW; Jung KC; Kim YT; Heo DS; Kim TM; Jeon YK
Oncologist; 2019 Aug; 24(8):e740-e748. PubMed ID: 30696721
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of the Prevalence of Microsatellite Instability in prostate cancer and Response to Immune Checkpoint Blockade.
Abida W; Cheng ML; Armenia J; Middha S; Autio KA; Vargas HA; Rathkopf D; Morris MJ; Danila DC; Slovin SF; Carbone E; Barnett ES; Hullings M; Hechtman JF; Zehir A; Shia J; Jonsson P; Stadler ZK; Srinivasan P; Laudone VP; Reuter V; Wolchok JD; Socci ND; Taylor BS; Berger MF; Kantoff PW; Sawyers CL; Schultz N; Solit DB; Gopalan A; Scher HI
JAMA Oncol; 2019 Apr; 5(4):471-478. PubMed ID: 30589920
[TBL] [Abstract] [Full Text] [Related]
13. Carcinosarcoma of the prostate: case report with molecular and histological characterization.
Salvi S; Casadio V; Martignano F; Gurioli G; Tumedei MM; Calistri D; Gunelli R; Costantini M
Int J Biol Markers; 2018 Nov; 33(4):540-544. PubMed ID: 30101629
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.
Majzner RG; Simon JS; Grosso JF; Martinez D; Pawel BR; Santi M; Merchant MS; Geoerger B; Hezam I; Marty V; Vielh P; Daugaard M; Sorensen PH; Mackall CL; Maris JM
Cancer; 2017 Oct; 123(19):3807-3815. PubMed ID: 28608950
[TBL] [Abstract] [Full Text] [Related]
15. Selected news from the 2014 Genitourinary cancers Symposium: translating novel strategies into clinical practice.
Bianconi M; Santoni M; Massari F; Faloppi L; Del Prete M; Giampieri R; Ciccarese C; Modena A; Tortora G; Scartozzi M; Cascinu S
Future Oncol; 2014 Nov; 10(14):2103-6. PubMed ID: 25471023
[TBL] [Abstract] [Full Text] [Related]
